.webp)
Coreweave D
D
CRWV
53.110
USD
-3.49
(-6.17%)
Post Trading·51.680USD-1.430(-2.69%)
Last updated: · Delayed 15 min
Coreweave stock forecast 2026–2028What is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Analysts' average 12-month price target for Coreweave is 114.04, 114.7% above the current price of 53.11. Their targets range from 45.00 to 200.00.
Of the 27 firms that rated Coreweave in the past 12 months, 19 rate it buy or strong buy, 6 hold and 2 sell or strong sell (each firm at its latest rating): a Buy consensus.
12-month price target
114.04 USD
+114.72%
Analysts' 1-year price targets range from 45.00 to 200.00, with an average of 114.04.
Past year
1-year forecast
Strong sellStrong buy
Buy
27 ratings
| Buy | 19 | |
| Hold | 6 | |
| Sell | 2 |
12-month price target
| Highest target | 200.00 |
| Average target | 114.04 |
| Lowest target | 45.00 |
| Current price | 53.11 |
Coreweave price target historyWhat is an analyst price target? A price target is the price an analyst expects a stock to reach in 12 months. Arincen shows the average, high and low targets and the upside to the average.
Have analysts recently raised or lowered their Coreweave price target and rating?
See how analysts moved their price target
How analysts rate Coreweave, month by monthWhat is the analyst rating? The analyst rating sums up what the analysts covering a stock recommend, from strong buy to strong sell, by the share of them rating it a buy.
19 of 27 firms rate it buy now, against 11 of 22 in December 2025.
Buy Hold Sell
Each month: every firm at its latest rating from the 12 months before. Strong buys count as buys, strong sells as sells.
Coreweave analyst upgrades, downgrades and price targets
The latest rating change came on 19 October 2026, when Goldman Sachs upgraded Coreweave from Neutral to Buy. Its price target is 106.00, from 139.00. The most recent new target came from Argus Research on 12 November 2026: 100.00.
| Date | Firm | Rating | Price target | Change | Price then |
|---|---|---|---|---|---|
| 12 Nov 2026 | Argus Research Jim Kelleher | Reiterated · Buy | 100.00 | — | 55.03 |
| 11 Nov 2026 | Rosenblatt Securities John McPeake | — | 250.00 → 160.00 | -36.0% | 59.98 |
| 11 Nov 2026 | D.A. Davidson Gil Luria | — | 100.00 → 45.00 | -55.0% | 60.26 |
| 11 Nov 2026 | Stifel Nicolaus Ruben Roy | Reiterated · Hold | 120.00 → 60.00 | -50.0% | 48.73 |
| 11 Nov 2026 | Cantor Fitzgerald Brett Knoblauch | Reiterated · Overweight | 176.00 → 100.00 | -43.2% | 48.73 |
| 11 Nov 2026 | Mizuho Securities Gregg Moskowitz | — | 88.00 → 68.00 | -22.7% | 48.73 |
| 26 Oct 2026 | Raymond James Josh Beck | — | 75.00 | — | 54.24 |
| 23 Oct 2026 | Morgan Stanley | Reiterated · Equal Weight | 70.00 | — | 55.60 |
| 23 Oct 2026 | UBS | Reiterated · Buy | 120.00 → 105.00 | -12.5% | 55.60 |
| 21 Oct 2026 | Piper Sandler | Reiterated · Overweight | 153.00 → 124.00 | -19.0% | 62.13 |
| 19 Oct 2026 | BNP Paribas Daniel Wang | — | 192.00 → 117.00 | -39.1% | 61.12 |
| 19 Oct 2026 | Goldman Sachs | Upgraded · Neutral → Buy | 139.00 → 106.00 | -23.7% | 61.39 |
| 19 Oct 2026 | MoffettNathanson | — | 92.00 → 89.00 | -3.3% | 61.39 |
| 15 Oct 2026 | Mizuho Securities Gregg Moskowitz | Reiterated · Neutral | 115.00 → 88.00 | -23.5% | 65.78 |
| 7 Oct 2026 | Northland Securities | — | 200.00 | — | 88.19 |
| 1 Oct 2026 | Rosenblatt Securities John McPeake | Reiterated · Buy | 250.00 | — | 87.12 |
| 24 Sept 2026 | JP Morgan | Upgraded · Neutral → Overweight | — | — | — |
| 22 Sept 2026 | UBS | — | 120.00 | — | 86.76 |
| 21 Sept 2026 | BTG Pactual | — | 125.00 | — | 85.66 |
| 24 Aug 2026 | Truist Financial Arvind Ramnani | Reiterated · Buy | 155.00 → 165.00 | +6.5% | 83.84 |
| 21 Aug 2026 | Goldman Sachs Gabriela Borges | Reiterated · Neutral | 86.00 → 139.00 | +61.6% | 89.76 |
| 13 Aug 2026 | Roth Capital | — | 150.00 → 145.00 | -3.3% | 111.16 |
| 13 Aug 2026 | Barclays | Reiterated · Equal Weight | 120.00 → 105.00 | -12.5% | 107.73 |
| 12 Aug 2026 | Truist Financial Arvind Ramnani | Reiterated · Buy | 126.00 → 155.00 | +23.0% | 106.77 |
| 12 Aug 2026 | Piper Sandler James Fish | Reiterated · Overweight | 151.00 → 153.00 | +1.3% | 106.75 |
| 12 Aug 2026 | Cantor Fitzgerald | Reiterated · Overweight | 178.00 → 176.00 | -1.1% | 109.92 |
| 12 Aug 2026 | Bernstein | Reiterated · Underperform | 67.00 → 74.00 | +10.4% | 107.96 |
| 12 Aug 2026 | Cantor Fitzgerald Brett Knoblauch | — | 156.00 → 178.00 | +14.1% | 90.32 |
| 12 Aug 2026 | Wells Fargo Michael Turrin | Reiterated · Overweight | 155.00 → 160.00 | +3.2% | 90.32 |
| 12 Aug 2026 | Mizuho Securities Gregg Moskowitz | Reiterated · Neutral | 110.00 → 115.00 | +4.5% | 90.32 |
| 12 Aug 2026 | Robert W. Baird Rob Oliver | — | 100.00 → 130.00 | +30.0% | 90.32 |
| 7 Aug 2026 | Deutsche Bank | — | 135.00 → 150.00 | +11.1% | 85.33 |
| 3 Aug 2026 | Piper Sandler James Fish | — | 151.00 | — | 85.76 |
| 22 Jul 2026 | Truist Securities | Upgraded · Hold → Buy | — | — | — |
| 21 Jul 2026 | Truist Financial | — | 131.00 → 126.00 | -3.8% | 79.58 |
| 21 Jul 2026 | Robert W. Baird Rob Oliver | — | 100.00 | — | 79.58 |
| 21 Jul 2026 | Jefferies Brent Thill | Reiterated · Buy | 160.00 → 150.00 | -6.3% | 73.06 |
| 2 Jun 2026 | BNP Paribas | — | 192.00 | — | 124.82 |
| 18 May 2026 | D.A. Davidson Gil Luria | — | 110.00 → 100.00 | -9.1% | 101.30 |
| 18 May 2026 | DA Davidson | Downgraded · Buy → Neutral | — | — | — |
| 11 May 2026 | Barclays | Reiterated · Equal Weight | 106.00 → 120.00 | +13.2% | 114.15 |
| 8 May 2026 | Deutsche Bank | — | 140.00 → 135.00 | -3.6% | 116.18 |
| 8 May 2026 | Truist Financial | Reiterated · Hold | 84.00 → 131.00 | +56.0% | 128.84 |
| 8 May 2026 | Wells Fargo Michael Turrin | Reiterated · Overweight | 125.00 → 155.00 | +24.0% | 128.84 |
| 8 May 2026 | Roth Capital | — | 110.00 → 150.00 | +36.4% | 128.84 |
| 8 May 2026 | Mizuho Securities | Reiterated · Neutral | 105.00 → 110.00 | +4.8% | 128.84 |
| 4 May 2026 | Jefferies | — | 120.00 → 160.00 | +33.3% | 125.43 |
| 29 Apr 2026 | Oppenheimer | Reiterated · Outperform | 150.00 | — | 105.53 |
| 20 Apr 2026 | Barclays | — | 90.00 → 106.00 | +17.8% | 113.53 |
| 16 Apr 2026 | Cantor Fitzgerald Brett Knoblauch | Reiterated · Overweight | 149.00 → 156.00 | +4.7% | 118.69 |
Coreweave EPS and revenue estimatesWhat are estimate revisions? Estimate revisions are the changes analysts make to their EPS and revenue forecasts for the years ahead. They show whether expectations are rising or falling.
Revenue
ReportedEstimate
EPS
ReportedEstimate
Does Coreweave beat earnings estimates?What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
On average, analysts' EPS estimate was 80.4% off the result, either way, and their revenue estimate 6.3%, over the last 7 quarters.
- EPS beats
- 2 / 7
- Revenue beats
- 7 / 7
- Average EPS surprise, last 7What is an earnings surprise? An earnings surprise is how far a company's reported EPS or revenue came above or below the analysts' average estimate, in percent.
- -53.3%
- Since
- May 2025
| Quarter | Report date | EPS estimate | Reported EPS | Surprise | Revenue estimate | Reported revenue | Surprise |
|---|---|---|---|---|---|---|---|
| Q3 FY2026 | 10 Nov 2026 | -1.27 | -1.27 | 0.0% | 3.54B | 3.66B | +3.3% |
| Q2 FY2026 | 11 Aug 2026 | -1.21 | -1.03 | +14.9% | 2.55B | 2.58B | +0.8% |
| Q1 FY2026 | 7 May 2026 | -0.92 | -1.11 | -20.7% | 1.97B | 2.08B | +5.5% |
| Q4 FY2025 | 26 Feb 2026 | -0.50 | -0.56 | -11.7% | 1.55B | 1.57B | +1.5% |
| Q3 FY2025 | 10 Nov 2025 | -0.40 | -0.08 | +79.7% | 1.29B | 1.36B | +6.1% |
| Q2 FY2025 | 12 Aug 2025 | -0.23 | -0.27 | -16.4% | 1.08B | 1.21B | +12.1% |
| Q1 FY2025 | 14 May 2025 | -0.12 | -0.60 | -419.3% | 857.10M | 981.63M | +14.5% |
Coreweave stock price 2026–2028: scenariosHow are the stock price scenarios calculated? Bear, base and bull prices for the years ahead: the analysts' EPS estimates times the lowest, average and highest P/E of the stock today and at its last five year ends, or of its peers.
There are no price scenarios for Coreweave: its P/E has been above 60, or from losses, too often in the last five years to price its earnings at, and similar companies' P/Es put its value too far from its price to stand in. The earnings analysts expect are in the estimates above.
Most undervalued US stocksHow does Arincen work out a stock's fair value? Fair value is our estimate of a share's price at the P/E the company usually trades at, with a low to high range around it.
| Stock | Price | Fair value | Upside |
|---|---|---|---|
| 35.760 | 71.4258Price 35.76193 | +99.7% | |
| 29.080 | 56.2434Price 29.0896 | +93.4% | |
| 240.360 | 464.26205Price 240.36627 | +93.2% | |
| 202.040 | 384.58163Price 202.042,644 | +90.3% | |
| 161.340 | 305.52160Price 161.34396 | +89.4% | |
| 125.395 | 237.44178Price 125.40297 | +89.4% | |
| 159.580 | 300.48225Price 159.58376 | +88.3% |
Furthest below the fair value on each stock's page, updated every day.